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Abstract
Approximately 30 percent of epilepsy patients suffer from refractory temporal lobe epilepsy
which is commonly treated with resection of the epileptogenic tissue. However, surgical
treatment presents many challenges in locating the epileptogenic focus and thus not all
patients become seizure-free following surgery. Advances in techniques can lead to improved localization of the epileptogenic zone and may be validated by correlating MRI
with neuropathology of the excised cortical tissue. Focal cortical dysplasias are a neuropathological group of cortical malformations that are often found in cases of refractory
epilepsy, however, they are subtle and difficult to quantify. The purpose of this research
is to employ histology image analysis techniques to better characterize these abnormalities at the neuronal and laminar level, allowing for correlative MRI-histology studies and
improved lesion detection in medically intractable TLE.
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Chapter 1
Introduction
1.1
1.1.1

Epilepsy
Introduction to Epilepsy

Epilepsy is a set of chronic neurological disorders that are characterized by abnormal
neuronal activity causing recurrent seizures and affects approximately 65 million people
worldwide [1]. Seizures are thought to be the consequence of an imbalance between inhibition and excitation, causing hyper-excitability of neuronal populations in the brain [2].
Seizures are categorized into two major groups based on onset, partial (focal) seizures,
and generalized seizure, with partial seizures being confined to a small neuronal population in the brain and categorized as either simple or complex. Simple focal seizures
result in exaggerated emotions or hallucinations, while complex focal seizures may result
in unconsciousness. The onset of abnormal neuronal activity that begins in one structure
of the brain and spreads throughout the entire brain is known as a generalized seizure
and is categorized by the presence of convulsive movements.
Despite many advances in epilepsy research over the years and the vast availability of
anti epileptic drugs (AEDs), the ability to eradicate seizures still remains highly limited.
Approximately 25 to 30% of all epilepsy patients are resistant to treatment with AEDs
1
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[3]. Refractory epilepsy is associated with a high level of social stigmatization [4],
decreased life expectancy [5], and other co-morbidities, ultimately placing a burden on
patients’ quality of life in addition to an economic burden [6, 7].
Temporal lobe epilepsy (TLE) is the most common cause of intractable refractory
seizures and was described in detail by the International League Against Epilepsy (ILAE)
in 1985 [8]. It is characterized by recurrent partial seizures that originate from the
medial or lateral temporal lobe. Patients who suffer with medically intractable temporal
lobe epilepsy are potential candidates for anterior temporal lobectomy (ATL) and it has
proven to be a successful treatment, particularly in the presence of an associated lesion
that is identifiable with neuroimaging techniques [9]. However, surgical treatment fails to
provide a seizure-free outcome in 20 to 40% of TLE patients [10–13]. The reasons behind
surgical failure vary from one patient to another, therefore the correct identification of
the epileptogenic zone is important for preparing and planning the surgical resection [14].

1.1.2

Temporal Lobe Anatomy

The temporal lobe, seen in Figure 1.1, is one of four regions within the cerebral cortex and
is associated with memory, speech perception and language comprehension in addition to
visual, auditory and olfactory senses [15]. It’s comprised of three cortices which consist
of a six-layered neocortex, a three-layered archicortex that includes the hippocampus,
the prepiriform area, the uncal semilunar gyrus, and the parahippocampus, the transitional region between the neocortex and the archicortex. The mesial structures of the
temporal lobe consist of the hippocampus, amygdala, uncus, parahippocampal gyrus and
entorhinal cortex, while the lateral temporal lobe comprises of the neocortex, which can
be seen in Figure 1.2 [16].
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Figure 1.1: Position of the temporal lobe in the cerebral cortex. Modified from Henry
Gray’s anatomy: Figure 728. Licensed under Public domain via Wikimedia Commons.

Figure 1.2: Structures of the temporal lobe demonstrating the outer temporal lobe neocortex along with the primary mesial structures underneath
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Neocortical Architecture

For most of the nineteenth century, there was much debate surrounding the organization
of the nervous system. There were differing conclusions about the structure of the nervous
system due to the poor resolution of the microscopes available at the time. It was Santiago
Ramon y Cajal who suggested that the neuron was the functional unit of the nervous
system [17].
There are several cell types in the cerebral cortex. The pyramidal cells are the primary
cell type within layers III and V. Their most prominent feature is their pyramidal shape
with an apical dendrite that extends to layer I. The thin axon that arises out from the
base of the cell has long process that leaves the cortex and connects with other brain
regions by extending through the white matter deep to the cortex. The granule cells
are seen most prominently in layer IV and their axons remain within the cortex [18].
Neuroglia cells are not neurons but are supporting cells within the nervous system. The
basic structure of a neuron, along with a neuroglial cell, can be seen in Figure 1.3.
The neocortex is the newest part of the cerebral cortex and is a distinguishing feature
of the mammalian brain. The work of Brodmann in the early 20th century showed that
the majority of the cerebral neocortex has six distinct cell layers in a lamina structure and
covers most of the surface of the cerebral hemispheres [19]. Each cortical layer contains
various types of neurons differing in shape, size and density. The six layers of this part
of the cortex are numbered from the pial to the white matter, as seen in Figure 1.4.
Layer I is the molecular layer, which contains very few cell bodies; layer II the external
granular layer, containing small densely-packed pyramidal neurons; layer III, the external
pyramidal layer, with mid-sized pyramidal neurons; layer IV, the internal granular layer,
which is the most heavily populated layer containing granule cells; layer V, the internal
pyramidal layer, contains the largest pyramidal neurons; and layer VI the multiform, or
fusiform layer that contains a variety of neurons [18].
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Figure 1.3: Basic structure of a neuron. Adapted from the Blausen Gallery, 2014.
Wikiversity Journal of Medicine. Licensed under the Creative Commons Attribution
3.0 Unported license.
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Figure 1.4: Cajal drawing showing cortical lamination in the human cerebral cortex.
Modified from Santiago Ramon y Cajal’s ”Comparative study of the sensory areas of the
human cortex”, page 361. Licensed under Public domain via Wikimedia Commons.
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Pathology & Epileptogenicity of Temporal Lobe Epilepsy

Epileptogenesis

In order for the brain to function normally, neurons must maintain a highly interconnected and organized structure. Epileptogenesis is the sequence of events that converts
a normal brain into one that supports seizures [2]. While there are many theories surrounding the current understanding of epileptogenesis, the changes that occur during
epileptogenesis are poorly understood.
Cortical development, known as corticogenesis, is a highly complex and regulated
process that starts from neurogenesis and proceeds in a series of precisely ordered steps
of neuronal proliferation, neuronal migration and cortical organization [20]. Primitive
neuronal cells originate in the neural tube and proliferate to become neuroblasts. The
neuroblasts migrate along radial glial scaffolding and the cells organize into various layers
establishing the cortical laminae structure, as described previously in Section 1.1.3. At
this point the neurons undergo differentiation and synaptogensis, followed by myelination
[21]. However, if this process is at all disrupted, abnormalities may form in the neocortical
structure and individual cellular morphologies [22].
With recent advancements in neuroimaging, genetics and molecular biology there
has been an increased awareness of cerebral cortex development and neuropathologic
changes, especially in children [23]. Malformations of cortical development (MCD) are
developmental brain lesions characterized by disruptions and abnormalities of the cerebral
cortex and are inherently epileptogenic. These malformations consist of a wide group of
disorders in which approximately 25% to 40% of intractable epilepsy is associated with
MCD [24] and focal cortical dysplasia (FCD) is the most common presentation of MCD
in epilepsy [25].
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Focal Cortical Dysplasia
Taylor first used the term FCD in 1971 to describe cortical abnormalities found in patients
who presented with refractory partial epilepsy [26]. This term includes a wide range
of lesions including disorganized cytoarchitecture, disruption of cortical lamination, disruption of radial organization and abnormal neuronal morphologies.To categorize these
lesions, the ILAE recently introduced a three tier classification system that differentiates
the various epileptogenic lesions known as FCDs.
FCD Type I is recognized as an isolated malformation with abnormal cortical layering,
either showing radial abnormalities, characterized by microcolumns, in the cortical architecture (FCD Type Ia) or loss of the tangential architecture (FCD Type Ib), consisting
of blurring between layers and the white matter, or complete loss of neuron populations.
In addition, FCD Type Ic includes both lesion types, FCD Type Ia and FCD Type Ib,
demonstrating both abnormal radial and tangential lamination patterns in the cortex.
FCD Type II is a malformation that presents altered cortical layering in addition to
specific cytological abnormalities which may include FCD Type IIa, comprising the presence of dysmorphic neurons (neurons with significantly enlarged cell body and nucleus,
malorientation or accumulation of neurofilament proteins) or FCD Type II presenting
with dysmorphic neurons in addition to balloon cells. FCD Type III refers to architectural abnormalities that are associated with a lesion. These include lesions that are
linked to hippocampal sclerosis (FCD Type IIIa), tumours (FCD Type IIIb), vascular
malformations (FCD Type IIIc) and other principal lesions acquired during early life
(FCD Type IIId) [27].
Although the proposed ILAE classification system for FCD exists, there is currently
a lack of research towards providing objective, quantitative methods for characterization
of cortical dysplasia in epilepsy. Recently, Muhlebner et al [28] systematically analyzed
histological features in 52 epilepsy patients with evidence for FCD. They assessed measurements of cellular profiles , cortical thickness, heterotopic neurons in white matter
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and myelination and compared these measures to the patients’ FCD assigned classification. Cellular profiles were based on measurements of the area of individual cell bodies
and the diameter of neuronal cell bodies. Although their methodology presented a semiquantitative approach in assessing morphological parameters for FCD subgroups, further
work is required to better quantitatively characterize whole sections of cortical tissue.
Many previous studies demonstrating a quantitative analysis of neuropathology in
epilepsy have taken the approach of assessing the field fraction of a given histology slide
[29, 30]. Field fraction estimate is a commonly used measure representing the fraction of
positively stained pixels in each field. However, field fraction provides limited information
with respect to to the cortical architecture in epilepsy, thus further measures will allow
for better analysis of architectural abnormalities. There have also been studies that have
provided measures of neuron densities in both the cortex [31–33] and white matter [34,
35], however, since white matter neurons are so sparse, histological measurements in those
cortical regions are limited and neuronal density alone is not a sufficiently specific method
to encompass the entire spectrum of abnormalities in FCD. In addition, many of these
studies involve only hippocampal histology or rely on user-intensive stereology methods
[31, 35]. A study correlating cortical dysplasia with severity of seizures has shown that
seizure frequency correlates well with the histologic grade [36]. Since resections in
patients with FCD present a higher degree of complexity, there is a need for further
quantitative and automated measures that can better apply the ILAE classification of
FCD and assess abnormalities in cortical architecture.

1.1.5

Diagnostic Procedures

EEG
An electroencephalogram (EEG) detects electrical activity in the brain using electrodes
attached to the scalp. Neurons communicate via electrical impulses and this activity
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shows up as waveforms on an EEG recording. In epilepsy diagnosis, abnormal waveforms often appear as spikes and wave patterns that can be used for lateralization and
localization of the epileptic focus. Although beneficial in epilepsy monitoring, electroencephalograghy (EEG) alone is not sufficient for surgical planning or the determination of
epileptogenic zones [37, 38].

Neuroimaging
Neuroimaging in epilepsy utilizes many different approaches and modalities. In particular, Magnetic Resonance Imaging (MRI) has had a high impact on clinical diagnosis and
treatment in epilepsy, leading to a greater understanding of structural brain abnormalities
associated with seizure activity [39].
MRI is a medical imaging technique that is most commonly used to visualize detailed
internal structures of the body and makes use of the property of Nuclear Magnetic Resonance (NMR) to image nuclei of atoms inside the body. MRI is used over other medical
imaging techniques, such as computed tomography (CT) or X-rays, since it provides contrast between the various soft tissues in the body. This makes this technique especially
useful in imaging the brain and its varying tissues, particularly compared to CT that is
considered to be unhelpful in cases of intractable epilepsy [39].
Conventional MRI, however, is inadequate for patients with refractory epilepsy, since
FCD are often subtle and difficult to detect. The ILAE guideline for neuroimaging in
patients with epilepsy recommend a dedicated MRI protocol for all patients with any
new onset of seizure activity [40]. Additionally, the ILAE Commission on Neuroimaging
recommends a specialized epilepsy MRI protocol in all patients with intractable epilepsy
[41].
Other imaging modalities that are used in the evaluation of refractory epilepsy include
functional Magnetic Resonance Imaging (fMRI), Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) but the use of these
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imaging modalities for diagnostic purpose are currently outside the scope of this project.

1.1.6

Surgery

Surgical excision of the epileptogenic zone is the current standard of care for intractable
focal epilepsy [42]. The first known surgical intervention of temporal lobe epilepsy
was performed by Horsely in 1886 . He carried out surgical resections, removing lesions
based on predicted seizure semiology [43]. Today, epilepsy patients are recommended for
surgery when drug intervention or other therapies are ineffective in controlling seizures.
In addition, there should be a reasonable likelihood that the seizure onset is focal and
limited to one region of the brain. The process of recruiting surgical candidates involves a
combination of evaluations including electrophysiological and neuroimaging instruments.
The goal of surgery is to achieve seizure freedom and improve quality of life, by removal
of the epileptogenic tissue, with minimal neurological or cognitive deficits to the patient.
Temporal lobe resections are relatively safe procedures with mortality rates close to zero
and continuously improving surgical techniques [44,45]. Currently there are two surgical
methods that are used in the treatment of medically intractable TLE, the standard ATL
or selective amygdalohippocampectomy (SAH).

Anterior Temporal Lobectomy
An ATL is the complete resection of the lateral temporal and mesial temporal structures
of the brain. Standard general anaesthesia is most commonly used, however, some centres employ an awake craniotomy in order to perform intraoperative functional cortical
mapping to avoid damage to critical regions.
The procedure first involves the en bloc removal of approximately 3-6 cm of the lateral
temporal neocortex, which allows for better visualization of the mesial structures. The
resection of the deeper mesial structures typically involves the removal of the hippocampus, amygdala, uncus, parahippocampal gyrus and entorhinal cortex [46]. The en bloc
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removal of these structures allows for pathologic examination of the specimen following
surgery in comparison to an aspiration technique using a Cavitron Ultrasonic Surgical
Aspirator (CUSA), which does not preserve the tissue for examination [47].

Selective Amygdalohippocampectomy
During SAH, the amygdala and hippocampus are targeted for removal, while the surrounding structures, including the neocortex of the temporal lobe, are preserved. This
procedure is considered to be minimally invasive and is typically used for patients with
clear evidence of mesial temporal lobe seizure foci without lateral temporal neocortex
indications.
During this procedure the patient is positioned similarly to the ATL but a smaller
linear or curvilinear incision is used [46]. Typically, the mesial resection of this procedure
is performed using an ultrasonic aspirator for much of the tissue, which does not allow
for later pathologic examination, however, en bloc removal of the hippocampal structure
is possible [46].

Surgical Risks and Outcomes
Surgical complications from temporal lobe resective procedures are relatively uncommon
[46]. However, the most commonly associated neuropsychological risks involved with temporal lobe surgery are memory loss, visual field deficits, speech difficulties and emotional
or personality changes. Surgical complications involve wound infection, postoperative
hydrocephalus, meningitis, and hematomas [44]. The mortality following surgery for
TLE is rare [45] and has been noted to be between 0% and 3.5% across several studies
[44]. Accurate knowledge of potential risks and complications is important for preventing them and many of the factors surrounding surgical complications can be avoided a
thorough medical screening and patient history [48].
Following temporal lobe surgery, approximately one-third of patients continue to ex-
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perience seizures [49]. Surgical treatment presents many challenges in locating the
epileptogenic focus and thus not all patients become seizure-free following surgery. For
this reason, further research is necessary to ensure seizure freedom in a higher percentage of epilepsy patients. The most important predictor of a successful resection is the
complete resection of the epileptogenic zone as detected by MRI prior to the surgery.

1.1.7

MRI-Histology Correlation

The key to identifying epileptogenic abnormalities in epilepsy patients relies heavily on
a multi-parametric approach. Advances in MR imaging techniques can lead to improved
localization of the epileptogenic zone and may be validated by correlating MRI with
histology of the excised cortical tissue following surgery [32,50–53]. As mentioned previously in Section 1.1.4, malformations, that are present in mildly dysplastic cortical tissue,
are often subtle and difficult to quantify. Using quantitative analysis techniques, the various pathologies in epilepsy lesions can be characterized into digital histology signatures,
with the expectation that abnormal tissue would have a different signature than that of
a normal tissue sample, as seen in Figure 1.5.
To perform a correlation study between MR images and histology images, an accurate registration must first be performed, as demonstrated in Figure 1.6. Thus far the
work by Goubran [54, 55] has demonstrated a robust registration pipeline that allows for
an accurate spatial correspondence of histology to ex-vivo MRI in addition to the registration between histology and in-vivo MRI. This process can present many challenges,
since often histological tissue is not available following surgery in the case of aspiration
techniques, and available tissue may be deformed from surgical resection or may present
with distortions from the various steps involved with histological tissue processing.
Currently, there is a lack of research in the relationship between neuroimaging and
histopathology. A 2011 surgical study demonstrated that dysplastic lesions are missed in
clinical MRI in up to 87% of cases with Type I FCD and 33% Type II FCD [56]. These
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poor detection rates are related to the limitations in current imaging resolutions in addition to a lack of quantitative characterization and analysis of FCD lesions. Additionally, a
study correlating MRI [32] to neuronal size and density found significant correlation but
further measures of cortical abnormality are necessary to accurately predict and identify
epileptogenic zones. These findings motivate the need for further MRI-histology in-vivo
correlation studies that are usable in pre-operative visualization and planning. Predictive
in-vivo histology maps would allow for the identification of epileptogenic zones prior to
surgery, thus improving surgical resection outcomes.

1.2

Histopathology

Histopathology is a component of pathology that refers to the examination of tissue
samples in order to study disease. The histological evaluation of tissue is critical to many
applications, and the quantification and characterization of specimens aids in specific
diagnoses.

1.2.1

Tissue Preparation

The process of histopathological examination begins with the acquisition of tissue samples
via biopsy or surgery. Before the sample can be examined by the pathologist, it must be
prepared via the following four primary steps:

1. Fixation,
2. Embedding,
3. Sectioning, and
4. Staining,
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Fixation
The tissue is removed from the body and placed in a fixative in order to both preserve
and stabilize the tissue. Chemical fixatives work to preserve the tissue from degradation
and also help to maintain the structure of both the cells and other components of the
tissue. Standard fixation often uses a solution of formaldehyde, which is buffered and
osmotically balanced to minimize shrinkage, swelling, and other damage of the tissue
resulting in image artifacts.

Embedding
The fixation is followed by embedding, in which the water content of the tissue is removed with the use of solvents such as alcohol and xylene, and replaced by a solidifying
ingredient such as paraffin wax.

Sectioning
Paraffin blocks are placed onto the microtome for slicing. Sections for routine light
microscopy are typically between 5 µm and 10 µmin thickness. Although sections can be
cut in a number of directions, the standard method for pathological evaluation of tissue
is a cut made perpendicular to the tissue surface. The sections are then mounted onto
slides for analysis.

Staining
Since many tissues are colourless and transparent, structural and cellular details are
not visible unless the tissue is first stained to obtain contrast. Before staining, paraffin embedded sections must be rehydrated in a reverse process described in embedding.
Hematoxylin and eosin (H&E stain) is the most common stain used in the fields of histology and histopathology. First, hematoxylin stains the nuclei blue due to it’s affinity
to nucleic acids in the cell nucleus while eosin stains the cytoplasm pink. Immunohis-

Chapter 1. Introduction

17

tochemistry is the process of using antibodies to specifically visualize proteins within a
tissue sample.

1.2.2

Image Artifacts

Artifacts can result from each step in tissue processing and caution must be taken to
minimize these artifacts as much as possible. Tissue processing commonly leads to various
changes in the tissue specimen such as tissue shrinkage, inconsistent color changes, and
alterations of the cellular components and anatomical structures in the tissue. Various
deformations must be considered and accounted for in tissue analysis. Colour constancy
can cause particular issues for computer-aided analysis and is hard to control during the
staining process and pooling of the stain naturally occurs.
Ideal tissue preparation preserves cells in a form that most closely represents the tissue
in-vivo. However, this is not always practical within a clinical setting since in most post
mortem samples, cells have been deteriorating for several hours before fixation is possible.
Since the advent of digital histology and image analysis, this has become even more of a
problem since many automated image analysis algorithms have difficulty handling image
artifacts [57]. Therefore, colour normalization and other image processing techniques
may be required before analysis.

1.2.3

Digitization

In general, the procedure for automatic analysis of histology images typically begins with
the acquisition of the digital images. An image captured by a sensor is considered to
be a continuous function of two coordinates, x and y, within a plane. The digitization
process moves this function into a discrete matrix of M rows and N columns, with each cell
pertaining to the location of a pixel within the image. The two-dimensional digital image
is represented as a three-dimensional array in which x and y coordinates describe the
pixel position, while the z coordinate contains the pixel’s intensity value. In a greyscale
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image the z coordinate contains a single intensity value while in a colour image further
information is required thus a vector of intensity values represents the colour components.

1.3

Digital Histology Processing

The introduction of digital histology has allowed for the simplification of many aspects of
image processing involved in histology image analysis. However, manual interpretation
of tissue slides is still highly labour intensive and is a highly visual and subjective task
[58]. For this reason, there are many inconsistencies and risks for human error in image
analysis. Digital image analysis is an alternative approach to manual interpretation
by providing automatic, fast and reproducible results. The procedure for automatic
analysis of digital histology images most commonly involves image segmentation, feature
extraction, and the application of various learning algorithms [59, 60].

1.3.1

Colour Space

Colour represents a significant source of information within an image. A histological
digital image can be represented with various colour spaces with the most common representation in a digital image being the RGB model that refers to the red, green and blue
colour channels of an image. This colour model can be represented as a three dimensional
colour space as seen in figure 1.7, where each pixel is represented as a three-dimensional
vector (R,G,B) pertaining to the pixel’s intensity of each colour component.
Another common colour model, seen in Figure 1.8, is HSV, a transformation of the
RGB colour space in which a colour is decoupled from intensity and is represented by its
Hue, Saturation and Value. The hue (H) refers to the colour, saturation (S) is a measure
of white within the colour and value (V) describes the brightness of the pixel.
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Figure 1.7: RGB colour model mapped to a cube. Licensed under the Creative Commons
Attribution License.

Figure 1.8: HSV Colour Model represented as a single cone. Licensed under the Creative
Commons Attribution License.
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1.3.2

Colour Deconvolution

In pathology, image processing algorithms often use colour for detection of specific proteins and to separate various cellular structures within a tissue sample. In histologic
staining, in most cases tissue samples are stained with several colours. The goal of colour
deconvolution is to separate the image into three colour channels, indicating the distribution of the staining. This method is based on the absorption characteristics of an
individual stain. One of the most common methods of colour deconvolution is based on
the transformation of an RGB image to a single colour channel and was proposed by
Ruifrok and Johnston [61]. The technique uses the principles of the Lambert-Beer law
where the intensity of light over a thickness, x, in the sample is:

Ix = I0 e−αcx

where I0 is the incident intensity; α is the absorption factor of the stain;

(1.1)

c is the

concentration of the stain and the product αcx is the optical density.
This equation can be used to model the image formation process in bright field microscopy. Since images are captured by three channels (red, green and blue), each having
known optical densities, the concentrations of stains can be determined for each pixel
location which can be used to obtain single stain images. To perform the stain separation, an orthonormal transform of the RGB image is performed, providing information
regarding the stain’s concentration. This transformation must be both orthogonal and
normalized to allow for specific staining information and a balanced representation of the
absorption factor, α, for each stain. The normalized OD matrix, M, for an example case
of hematoxylin, eosin and DAB can be seen in Figure 1.9 [61].
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Figure 1.9: Normalized Optical Density matrix for Haematoxylin, Eosin and DAB

1.3.3

Image Segmentation

Segmentation is the process of dividing an image into meaningful regions or categories
and is one of the most important tools used in image analysis. Meaningful regions are
separated from the background and from each other using a variety of segmentation
techniques, including region-based and edge-based methods. The use of further image
analysis such as feature extraction and object classification, depend on the result of the
segmentation and therefore it is necessary for segmentations to be as accurate as possible.

Thresholding

Image thresholding techniques are simple, well known and intuitive. The purpose of a
thresholding procedure is to determine an intensity value, called the threshold, which
separates the image into desired regions within an image. The segmentation is then
achieved by grouping all pixels with intensity greater than the threshold into one subset,
and all other pixels into a separate set. These global methods are effective when the
intensity levels of the objects of interest fall entirely outside the range of background
intensity levels. However, since spatial information of the image is ignored, blurred
region boundaries can be problematic.
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Watershed Segmentation
The watershed transformation algorithm was formulated by Beucher and Lantujoule and
is one of the oldest segmentation techniques [62]. The watershed transformation is
useful since it provides a means to separate overlapping objects and allows for a lower
computation time and more accurate result compared to other existing segmentation
methods [63]. Unfortunately, using a standard morphological watershed algorithm on
an image often results in over-segmentation due to the presence of many local minima. An
over-segmentation is the process by which objects within an image are segmented from the
background but are themselves segmented, resulting in fractured image components. To
combat this problem, there have been many proposed solutions in literature to decrease
over-segmentation in watershed algorithms by reducing the number of minima [64, 65].
A major enhancement of the watershed transformation, found to be particularly useful
in cell segmentation, consists in ’flooding’ the topographic surface using a set of defined
markers and is known as the marker-based watershed algorithm [66]. In a marker-based
watershed segmentation both foreground and background markers are indicated and be
determined using a number of techniques such as edge detection, morphological filtering
and thresholding.

1.3.4

Histology Image Analysis

Quantitative measurement is usually the ultimate goal of histological image analysis.
Once an image has been segmented into meaningful regions and objects, various measurements can be made on these objects. Perhaps the most common image representation
for histology images is the feature vector. Feature vectors can be built up for each pixel,
for regions, sub-blocks or for the complete image. The dimensionality of the feature
vector is the most important aspect to be considered, in order to make sense in the way
they will be interpreted and processed.
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An alternative image representation is to preserve the descriptors for all objects in the
image. Objects in histology images can be cells, nuclei, glands or simply sub-blocks. For
each of those objects, a feature vector is constructed and all these vectors are organized
in a table or matrix. Note that the number of objects from image to image may be
different, while the length of the feature vector is fixed.

1.4

Thesis Objectives

The overall goals of this thesis can be defined as follows:
1. To develop and validate a segmentation process to individually delineate neurons
in histopathology specimens.
2. To investigate histological image features that are associated with epilepsy lesions
and create a means of classifying regions of epileptic tissue.
3. To relate findings to clinical applications relevant to intractable TLE.

1.5

Thesis Outline

The following chapters in this thesis indicate how these objectives were achieved.

1.5.1

Chapter 2 - Neuron Segmentation, Feature Extraction
and Clinical Applications

The focus of this chapter is to develop an automated segmentation and analysis pipeline
that can assess regions of neuronal tissue. It presents methodology and validation for
using specific features associated with FCD. A quantitative cortical architecture histology
analysis is also applied to clinical data and the developed algorithms are assessed for
clinical relevance in relation to FCD in temporal lobe epilepsy.
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Chapter 3 - Conclusions

This chapter will detail the conclusions and impact of the research included in this thesis,
along with a discussion of limitations within the work. Future directions of the project
will also be discussed.
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Chapter 2
Segmentation, Feature Extraction &
Clinical Applications

2.1

Introduction

The purpose of applying image processing techniques to the histopathology ranges from
cell counting and cell type classification, to calculating quantitative measurements of
morphological, histochemical and immunohistochemical features from images, and determining whether a specific pathology is present within the tissue samples. Numerous
commercial pathology analysis platforms are available with the increase of whole slide
imaging systems in digital pathology, thus improvements have been made in both the
quantity and quality of data collected from histological analysis [1].
Despite the International League Against Epilepsy (ILAE) classification system for focal cortical dysplasia (FCD), there is still a lack of research towards automated and quantitative methods that are able to accurately characterize dysplastic lesions in epilepsy.
Field fraction estimate is a commonly used measure, utilized in histology analysis and
represents the fraction of positively stained pixels in each field [2]. However, with respect
to cortical architecture, field fraction is less sensitive to the reciprocal nature of size and
34

Chapter 2. Segmentation, Feature Extraction & Clinical Applications 35
density within cortical layers. The addition of more specific and sensitive measures in localized regions will allow for better analysis and detection of architectural abnormalities.
Another study assessed measurements of cellular profiles (cell body area/size), cortical
thickness, myelination and number of heterotopic neurons in white matter and performed
a correlation study with the patients ILAE guided FCD [3]. Although this methodology
presented a semi-quantitative approach in assessing morphological parameters for FCD
subgroups, further work is required to better quantitatively characterize whole sections
of cortical tissue, including an automated approach.
Neuron density is often studied in white matter regions [4] since increased neuron
populations in white matter is indicative of FCD [5], however, more detailed and informative measures such as neuron size, neuron density, neuron clustering, neuron orientation,
and neuron eccentricity are needed to better quantify and assess the full cortical architecture in epilepsy. Typically, neurons are radially oriented within the cortex, however
in many disease states including epilepsy, mal-orientation occurs during the radial migration process of development [6]. In the same way, abnormal neuron migration during
cortical development may cause clustering in particular regions of the cortex. Additionally, neuron eccentricity has also been shown to present as abnormal in disease states,
as it is indicative of neuron morphology and is therefore a beneficial feature is assessing
neuronal abnormalities [7,8]. Overall, there is a need for a more automated method that
can apply the ILAE classification of FCD, resulting in better detection of abnormalities
in the cortex. The work in this thesis focuses on features present in FCD categories Type
I and II.
In this chapter I present a technique to automatically segment neurons from ImmunoHistoChemistry (IHC) stained histology slides and extract relevant features, to assess
the architecture and abnormalities of neuronal tissue. The proposed method uses colour
deconvolution, histogram thresholding and marker-based watershed segmentation to delineate individual neurons before extracting relevant neuronal features. This study also
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presents the clinical applications and relevance of using more specific neuronal measures
in assessing FCDs in temporal lobe epilepsy (TLE).

2.2
2.2.1

Methods
Patient Recruitment and Surgery

Patients suffering from medically intractable TLE and candidates for anterior temporal
lobectomy (ATL) were recruited as part of a ongoing research study at the Robarts
Research Institute. Of this cohort, a subset of twelve patients were selected for analysis
within this project. This subset included patients with available NEUN stained neocortex
slides since other patients had only mesial structures and alternatively stained slides
available. Patients were also divided into two groups for clinical analysis, those with
verified FCD in the pathology report and those without documented FCD. The nonFCD patients had no report of architectural abnormalities.
This study was approved by the Health Sciences Research Ethics Board of Western
University, and informed consent was received from all patients before participation. Patients were scanned pre-operatively in clinical 1.5T Magnetic Resonance Imaging (MRI)
and were assessed with scalp electroencephalograghy (EEG) for seizure characterization.
In addition to the clinical protocols, patients were also scanned in 3T and 7T MRI research scanners at Robarts Research Institute. Table 2.1 summarizes the relevant patient
data used in this study.

2.2.2

Histological Processing

Following surgery both the hippocampus and neocortex were retrieved from the operating room and fixed in a 10% formalin solution overnight. The specimens were then
scanned in a 9.4T MRI at Robarts Research Institute. while immersed in a silicone-based
lubricant(Fomblin PFPE Lubricant, Solvay) to reduce air-tissue surface artifacts. The
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Subj ID

Sex

Age

Seizure Origin

Pathology

MRI

Validation

EPI P006

F

22

R

gliosis

normal

Y

EPI P008

F

40

L

gliosis

incidental

Y

EPI P015

F

40

R

gliosis, mild CD

abnormal

Y

EPI P016

F

25

L

incidental

Y

abnormal

Y

gliosis, atypical cells
in WM
gliosis, minor

EPI P021

M

20

L

architectural
abnormalities

EPI P027

F

41

R

gliosis

abnormal

EPI P033

F

32

L

gliosis

abnormal

Y

EPI P036

M

39

R

FCD type 1b, gliosis

abnormal

Y

EPI P037

M

23

L

gliosis, multifocal

normal

lesions, FCD type 1a
gliosis, focal minor
EPI P040

M

34

L

neocortical

abnormal

Y

abnormalities
EPI P043

F

33

R

gliosis

abnormal

EPI P044

M

39

R

gliosis, FCD type Ic

abnormal

Y

Table 2.1: Summary of patient demographics and clinical information including gender,age, seizure origin, histopathological findings in neocortex and MRI findings. Patients
used in the segmentation validation are denoted in the last column with ‘Y’. Clinical MRI
findings may also indicate abnormal findings in the hippocampus
specimens underwent a standard histological processing protocol of fixation, embedding,
sectioning, staining and digitization, performed at the Department of Pathology at London Health Sciences Centre - University Hospital. During this process the tissue specimen
was cut through the coronal plane into two halves, anterior and posterior. Each half of
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the specimen was then embedded in agar for stabilization during the slicing process.
The specimens were sectioned into 4.4 mm pieces in the anterior to posterior direction
and parallel to the initial cut, using a standard deli slicer. Each block was embedded in
paraffin for sectioning and placed on a microtome where 8 µm sections were cut from the
face of each block and mounted onto slides for staining.
For both hippocampal and neocortical specimens, one slide from each block was
stained with hematoxylin and eosin (H&E). Glial fibrillary acidic protein (GFAP) (polyclonal antibody) and neuronal nuclei (NeuN) (monoclonal antibody) were used for every
other block. Additional stains were ordered when necessary for diagnosis by the pathologist. Following staining, the resulting histology slides were digitized on a ScanScope GL
(Aperio Technologies, Vista, CA, USA) bright field slide scanning system in BigTIFF file
format, using a pixel resolution of 0.5 µm. Figure 2.1 shows an overview of the histology
processing steps described.

Figure 2.1: Pipeline outlining histological processing
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Several factors create limitations that dictate the protocols in tissue processing. The
committee governing tissue for research purposes requires that the remaining part of
the specimen blocks be reserved in a tissue archive in the case any future analysis is
needed. In addition the number of subjects in our study and number of stained sections
available is restricted due to the significantly increased costs associated with acquiring
and processing serial sections for both hippocampal and neocortical tissue specimens.

2.2.3

Programming Language

All programs for this project were written using MATLAB (The MathWorks Inc) version
9.0.0.341360 (R2016A), Service Pack 1, along with the Image Processsing Toolbox.

2.2.4

Neuron Cell Body Segmentation

The main challenges in segmenting cells in histology specimens, result from the fact that
the specimen is a 2-D representation of a 3-D tissue sample. This sectioning can result in
partially imaged nuclei, imaging of cells at non-conventional angles and damage due to the
sectioning process [9]. Furthermore, specimen sections have a finite thickness resulting in
overlapping or partially superposed cells and nuclei, often making it difficult to determine
one cell from its neighbour. Finally, imaging noise in the background regions and other
image artifacts result in additional errors. The end result of these limitations is a set of
objects that may differ considerably from the ideal cell shape in-vivo. The goal of this
study is to develop an efficient and accurate algorithm for detecting and segmenting cells
in 2-D histological images. This is a necessary step towards quantifying aspects of both
normal and diseased tissue architecture, therefore it is important to detect the correct
number of cells with high accuracy, and to delineate them with minimal human effort.
This detection method involves a two-step process in which the images first undergo a
colour deconvolution algorithm [10, 11] to separate individual colour staining within the
slide, followed by a marker-based watershed segmentation [12]. The overall segmentation
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process is illustrated in Figure 2.2.

Figure 2.2: Flowchart outlining the main steps of the proposed neuron segmentation
algorithm

Colour Deconvolution

In image processing, colour deconvolution is used to separate an image into three individual colour channels, indicating the distribution of stains used. This allows for the
detection of proteins and also allows for the digital segmentation of various cellular structures within a tissue sample. In the case of this research, the slides were stained with
both Haematoxylin and diaminobenzidine (DAB) chromogens, which appear as blue and
brown, respectively. The primary stain colour of interest is brown due to the DAB chromogen applied with NeuN antibody to stain the neuronal cell types in the histology slides.
The colour deconvolution method [10] is based on the orthonormal transformation of an
RGB image to a single colour channel and stain specific values for the optical density can
be determined by the relative absorption for red, green and blue on signal stained slides.
The normalized OD matrix for haematoxylin and DAB can be seen in Table 2.2 [11].
This method allows for the determination of stain densities in multiple stained slides,
providing a separation of the Haematoxylin and DAB staining. The process of translating the initial NEUN image to the deconvolved stained image can be seen in Figure
2.3.

Chapter 2. Segmentation, Feature Extraction & Clinical Applications 41
Stain Type

R(red)

G(green)

B(blue)

Haem

0.650

0.704

0.286

DAB

0.268

0.570

0.776

Table 2.2: The normalized OD matrix for haematoxylin and DAB

Figure 2.3: An example of colour deconvolution. This section is taken from a smaller
sampled image to show the neurons that will be segmented. a) Original NEUN image
b)Stain specific colour deconvolution algorithm applied to image, dark blue refers to the
positive DAB colour indicative of a neuronal cell type
Marker-Based Watershed Segmentation
A marker-based watershed algorithm was selected to segment neurons within each slide.
In general, a watershed transformation provides a means to separate overlapping objects
and also allows for a lower computation time and better accuracy compared to other
existing methods [13]. Specifically, a marker based watershed algorithm decreases the
over-segmentation problem of watershed algorithms by reducing the number of minima
within an image [14, 15]. The basic outline of the segmentation process used in this
research is shown in Figure 2.4.
This algorithm is based on the fact that an image can be considered as a topographic
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Figure 2.4: Flowchart outlining the steps of the watershed segmentation
surface where the gradient image gray-levels represent varying altitudes, as seen in Figure
2.5. Edges correspond to high watersheds while low-gradient object interior correspond
to catchment basins. These catchment basins are homogeneous regions in which all pixels
are connected with the basin’s minimum altitude (gray-level). The basins then represent
the regions within the resulting segmented image. Typically, watershed segmentation algorithms may produce highly over-segmented images with hundreds of catchment basins,
therefore, in order to overcome this problem region markers can be applied to generate
better segmentation results.

Figure 2.5: One-dimensional representation of watershed segmentation with a gray level
profile of image data. Local minima yield catchment basins and local maxima define the
watershed lines
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The first step in the segmentation process is to clean up the image, allowing for
easier processing in selecting foreground and background markers. This involves the
use of morphological operations of opening by reconstruction (an erosion followed by
reconstruction), to smooth the outside of the neurons and closing by reconstruction
(dilation followed by reconstruction) in order to smooth the inside of the neurons. This
combination of morphological operations allows for the creation of flat maxima inside
each neuron.
The complement of the reconstructed image is computed where in a binary image,
zeros become ones and ones become zeros. From this complement, the regional maxima
within the image can be determined. This creates a mapping of neuron centres within
the image, also known as the foreground markers to indicate areas of the image to be
included in the segmentation. The foreground markers are further processed to remove
small amounts of neuron debris and markers too small to be considered as a neuron.
The threshold for this is calculated such that the minimum area of a granule cell is
approximately 15 µm2 , following erosion in MATLAB with a 5x5 kernel. Anything smaller
than this is removed from the image.
The background of the image is marked using a thresholding operation, followed by
the computation of a skeleton by influence zones to thin the background such that pixels
in the background markers do not touch those in the foreground neuron markers. These
influence zones are computed using the watershed transform of the distance transform
of the thresholded image, and from this the watershed ridge lines can be determined.
The final step in the process is to compute the watershed transform of the segmentation
function. A gradient magnitude was used as the segmentation function since the gradient
is high at the borders of the objects but low within the objects. The gradient magnitude image is also modified so that the regional minima occurs only at foreground and
background marker pixels and from this the watershed segmentation can be computed.
Images generated demonstrating this process can be seen in Figure 2.6. The resulting
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segmentation can be used to extract neuron borders within the image, allowing for a fully
segmented binary image of neuron locations.

Figure 2.6: a)Flat maxima ‘markers’ indicating neuron positions b)watershed ridge lines,
based on the distance transform c) coloured watershed label matrix

2.2.5

Feature Extraction

Following segmentation, each slide was systematically divided into square tiles of size
100 µm x 100 µm, i.e. 200 x 200 pixel. For each tile, histopathologic features were
extracted and maps of each feature were later generated for every histology slide. The
features used included neuron count (density), neuron size (area), orientation, clustering,
eccentricity and field fraction, detailed as follows.
neuron density is evaluated as the number of neurons per unit volume and was extracted from an automated count of each neuron within a tile. Clinically, density
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may be an indicator of FCD in areas where there is significantly decreased neuron
density.
neuron size is calculated by the total number of pixels within a single neuron (from
MATLAB regionprops metric, area) and can be represented as area in µm2 . Most
often in epilepsy, large neuron size can be indicative of balloon cells, present in
Type IIb FCD.
orientation is a scalar value that specifies the angle in degrees between the x-axis and
major axis of the neuron’s inertia ellipse that has the same second-moments as
the region. The MATLAB function, region property (regionprops), orientation,
was used for this feature measurement. Since neuron orientation relies on other
factors, such as slide orientation during digitization, this measure was calculated as
a variance of angle rather than the exact value for clinical analysis. Orientation is
indicative of malformations in cortical development and is included in FCD Type
IIa [16].
clustering is calculated based on the mean Euclidean distance matrix of a set of neurons
and uses the MATLAB centroid to perform a pairwise distance calculation between
all neurons in the specified field. An adjaceny matrix is used to compare each
neuron to its neighbours. Clustering is also present in disease states as a result of
malformations in cortical development.
eccentricity is a measure of deviation from circularity in an object. This is measured
using MATLAB regionprops, eccentricity, and is the ratio of the distance between
the foci of the ellipse and its major axis length. The value is represented a scalar
between 0 and 1 for each neuron. As mentioned previously, eccentricity is indicative
of neuron morphology and therefore may be capable of assessing FCD in epilepsy.
field fraction estimate is a commonly used measure representing the fraction of posi-
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tively stained pixels in each field. Since field fraction is sensitive to the density and
size of cortical layers, the field fraction estimate is used to highlight the importance
of using other measures to analyze the cortical architecture.

2.2.6

Validation

To evaluate the performance of a segmentation technique the aim is to compare newly
developed and existing methods. In these sections, I will introduce metrics to quantitatively compare methods within an experimental trial and consider caveats of employing
them for different segmentation problems.
A gold standard method can be considered a benchmark to test against, however
actual ground truth knowledge is often not available. It has been established in medical
imaging that a surrogate gold standard is an expert interpretation of an image in the form
of a manual annotation, commonly found in the image segmentation literature as label
maps resulting from manual segmentations. In literature, the accuracy of a segmentation
method is determined in its score against a gold standard benchmark in terms of a specific
metric. Such a validation metric allows the accuracy of a segmentation to be quantified.
In this study the Dice similarity coefficient [17], a regional based metric, was used in
order to assess segmentation accuracy. The Bland-Altman difference plot was also used
to compare inter-rater reliability in addition to the performance between manual and
automated segmentation techniques.

Manual Segmentation
The same slide set that was employed for automated analysis was used for the manual
segmentation. In order to validate the accuracy of the segmentation, manual neurons
counts were performed systematically and compared to the resulting automated segmentation metrics. A protocol (see Appendix A) for manual neuron counting was established
with the following restrictions: Regions of Interest (ROI) were selected from the cortex in

Chapter 2. Segmentation, Feature Extraction & Clinical Applications 47
Aperio ImageScope software in field of size 500 µm x 250 µm. The ImageScope positive
pixel count algorithm was applied to the ROI in order to indicate the NeuN staining
within the image. Neuron size was measured to have at least a diameter of 4 µm [18],
using the ImageScope ruler tool, and general neuron appearance was evaluated, according to the prescribed protocol. Neurons touching the edge of the field of view were not
included in the total count to ensure only whole neurons where assessed. This was also
accounted for within the automated algorithm to maintain consistency. Neurons were
manually contoured in ITK-Snap software [19] and imported into MATLAB for further
analysis and comparisons.

Dice Similarity Coefficient
We used the Dice similarity coefficient as a measure of spatial overlap accuracy in the
evaluation of performance in automated and manual segmentation. It was also used in
this research as a validation metric of reproducibility between manual raters.

DSC =

2(A ∩ B)
A+B

(2.1)

where A defines the manually segmented region and B is the region obtained from the
segmentation algorithm output. This is illustrated visually in Figure 2.7. In segmentation
validation literature, Zijdenbos et al. [20], defined image segmentation as having a good
overlap when DSC > 0.7.
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Figure 2.7: Dice similarity coefficient as a measure of segmentation validation
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Bland-Altman Difference Plot
The Bland-Altman plot [21], or difference plot, is a graphical method to compare two
measurements techniques. This method is used to calculate the mean difference between
two quantitative measurements and constructs the limits of agreement, reporting the
95% limits. An example plot is shown in Figure 2.8. Bland-Altman plots offer another
approach to assessing agreement between measures, particular when two observers or
raters are assessing the same variable. Bland-Altman analyses provide information about
the interchangeability of two measures without assuming that either is the gold-standard
and can be of value in clinical settings. Additionally, Bland-Altman can be used to
compare a new technique with a gold standard, which in this case we compare the
automated segmentation with the assumed gold standard - the manual segmentation.

Figure 2.8: Example Bland-Altman Plot shows the difference between two methods.
Mean difference is -27.2 while the limits of agreement extend from -95.5 to 41.1. Plotting
the difference against mean also allows for investigation of the relationship between the
measurement error and the ground truth value. The visual examination of the plot also
allows for the evaluation of global agreement between the two measurements
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Orientation Feature Validation
A secondary validation was performed in order to assess the quality of the automated
neuron orientation analysis and a similar protocol to the contouring segmentation was
followed (see Appendix B). The orientation annotations were performed on previous
segmentations and only one raters slides were used. A straight line was drawn through the
centre of the neuron, with the orientation following the cell body from base to apex of the
neuron. The resulting annotations were imported into the MATLAB software for analysis
and comparison with the automated feature map of the same slide. To accurately compare
the distance between two given angles, a correction was applied to one set of angles such
that only the shortest distance between two angles was considered. This correction does
not change the data or orientation of the neuron but simply allows for a more accurate
representation of the distance between two neurons. A visual representation of this angle
correction can be seen in Figure 2.9

Figure 2.9: Angle correction applied such that only the smallest angle difference is considered

Spearman’s Rank Correlation Coefficient
Correlation is a statistical technique that can shows if pairs of variables are linearly
related and how strong this relationship is in a value between -1 and 1. The stronger
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the correlation, the closer the correlation coefficient approaches 1 or -1. A correlation
coefficient of zero indicates that a relationship does not exist between the two variables
[22].
Specifically, Spearman’s Rank correlation coefficient [23] is a technique which can be
used to assess the strength and negative or positive direction of a relationship between
two variables. It is considered to be useful when one or both variables are skewed and is
robust when there are extreme values [22].

2.2.7

Clinical Analysis

In order to assess the relevance of the described algorithms and features in terms of a
clinical setting, for each patient slide, manual labels were created in Aperio Image Scope
(Leica Biosystems) to delineate the 6 individual layers, seen in Figure 2.10. The protocol
for the manual layer segmentation is described in Appendix C. Only areas in which the
slide could be considered non-tangential cuts were included. In addition, any areas with
staining or other artifacts were excluded from the analysis.
These labels were imported into MATLAB and used as masks for the feature map
data. The patient data was divided into two categories for comparison, those patients
with pathologist verified cases of FCD (sample size = 3) and those without (sample size =
6). These masks were used to investigate whether layer-specific estimates of the selected
features are different between cortex without any identified pathology and those with
FCD. Cortical lamina was chosen to summarize each feature, since these features can
vary greatly across lamina and add additional variability to this comparison.

Two-way ANOVA
A two-way repeated measures anaylysis of variance (ANOVA) was used to determine
differences between the two patient groups and also between the six cortical layers for
each feature type (size, density, orientation, eccentricity and field fraction), These tests
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Figure 2.10: Layer label for EPI P037. Each colour represents a manually annotated
layer, from the pial in dark blue (layer 1) to layer 6 in dark red.
were corrected using Holm-Bonferroni multiple-comparison correction method and the
alpha (p) value was set to 0.05.

Holm Bonferroni Correction
When several hypotheses are considered, the problem of multiplicity becomes apparent:
The more hypotheses that are checked, the higher the probability of false positives occurring. The Holm-Bonferroni [24] method is an approach used to control the false-positive
error rate. All p-values are sorted in order of smallest (most significant) to the largest.
If the 1st p-value is greater than or equal to alpha/n, where n is the number p-values,
the procedure is stopped and no p-values are considered to be significant. Otherwise, the
1st p-value is significant and now the second p-value is compared to alpha/(n-1). This
process continues until the p-values are no longer significant or the correction has been
applied to all p-values.
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2.3
2.3.1

Results
Examples of Neuron Segmentation & Feature Maps

Figure 2.11 shows a visual depiction of the resulting segmentation. Our approach corrects
for under-segmentation and allows visually joint neurons to be separated. The complete
method gives a good final segmentation and the statistical results are presented in the
validation sections below.

Figure 2.11: Example of (a) original NEUN image, (b) colour deconvolution (c) image
thresholding and (d) watershed segmentation

The resulting segmentation allowed each of the features to be applied to individual
neurons and measurements taken. The following images are the whole-slide feature maps
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generated from the application of the segmentation described previously in Section 2.2.4,
followed by various neuron feature measurements applied to NEUN histology slides. Images in Figures 2.12 and 2.13 were generated using MATLAB.

Figure 2.12: Example of feature maps generated for Field Fraction, Neuron Density and
Neuron Size. The feature maps are generated from averaged values within a 100 µm2
section.
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Figure 2.13: Example of feature maps generated for Orientation, Clustering and Eccentricity. The feature maps are generated from averaged values within a 100 µm section.
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Inter-rater correlations
The Dice similarity coefficient (DSC) was also used to validate and evaluate the spatial
overlap between manual segmentations and reproducibility in neuron histology images,
illustrated on nine clinical examples. Table 2.5 displays the Dice similarity coefficient of
each subject comparing the overlap of segmentations from two different raters. The mean
DSC of 0.87 (range [0.86, 0.88]) was within the range of good reproducibility, as defined
by Zijdenbos et al in literature regarding image segmentation, where a good overlap is
regarded to have DSC > 0.70 [20].
Subj ID

Dice

EPI P006

0.88

EPI P008

0.86

EPI P015

0.87

EPI P016

0.86

EPI P021

0.88

EPI P033

0.87

EPI P036

0.86

EPI P040

0.88

EPI P044

0.86

Table 2.3: Dice Similarity Coefficients for inter-rater reliability in manual segmentations
The intraclass correlation coefficient for absolute agreement of average number of
neurons in a FOV was 0.97 (95% CI +0.89 to +0.99) while the ICC for average size of
neurons was 0.95 (95% CI +0.81 to +0.99).
The following Bland-Altman plots, in Figures 2.14 and 2.15, compare both size and
density between the two raters. The Bland-Altman plot for density demonstrates similar
results to that of the automated and manual comparison. The mean discrepancy is low
and the limits of agreement are acceptable to the clinical application of this method.
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There is no observable trend towards the amount of neurons within a given region.

Figure 2.14: Bland Altman plot comparing mean neuron density measurements across
two raters
The Bland-Altman plot for size has a very low mean discrepancy, indicating that
the two raters more similarly follow the neuron boundary in annotations, compared
to the previous resulting plot between manual and automated methods. The limits of
agreement are somewhat wide, but considering the inherent variability within neuron
size, these values can be considered acceptable.
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Figure 2.15: Bland Altman plot comparing mean neuron size measurements across two
raters
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2.3.2

Automated Contouring Validation

The Dice similarity coefficient (DSC) was used as a statistical validation metric to evaluate spatial overlap and the performance of manual segmentation reproducibility in neuron histology images, illustrated on nine clinical examples. Table 2.5 displays the Dice
similarity coefficient of each subject comparing the overlap of segmentations from two
different raters. The mean DSC of 0.77 (range [0.60,0.81]) was within the range of good
reproducibility (as defined by Zijdenbos) [20]. The Zijdenbos method of similarity has
been utilized previously in histological studies, verifying its ability to measure consistent
overlap in cell segmentation [25, 26].
Subj ID

Dice

EPI P006

0.60

EPI P008

0.80

EPI P015

0.81

EPI P016

0.73

EPI P021

0.80

EPI P033

0.80

EPI P036

0.79

EPI P040

0.79

EPI P044

0.80

Table 2.4: Dice Similarity Coefficients for comparing overlap between automated and
manual segmentations
The intraclass correlation coefficient (ICC) for absolute agreement of average number
of neurons in a region of interest was 0.96 (95% CI +0.86 to +0.99) while the ICC for
average size of neurons was 0.38 (95% CI -0.20 to +0.82). Although seemingly low,
the ICC for size represents an under-segmentation in the automated algorithm, resulting
from morphological operations such as erosion and dilation. As demonstrated in the DSC
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values, in the majority of cases, the neuron placement is correctly located.
The following Bland-Altman plots, in Figures 2.16 and 2.17, compare both size and
density between the manual segmentation and the automated segmentation. For density,
the average discrepancy is 6.1 neurons. Clinically, we can assume that this is a reasonable
degree of variability between automated and manual slides considering that most of the
regions used contained several hundred neurons. The limits of agreement, although
somewhat wide are still within reasonable quantities relevant to the application. There
is no observable trend in the data as indicated by the regression line.

Figure 2.16: Bland Altman plot comparing mean neuron density measurements between
the automated and manual segmentations
Comparatively, the Bland-Altman Plot in Figure 2.17 compares the size metric of the
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automated and manual techniques. There is a significantly under-estimation of size in
the automated method and this difference increases with larger neuron size. The limits
of agreement are also very wide.

Figure 2.17: Bland Altman plot comparing mean neuron size measurements between the
automated and manual segmentations
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2.3.3

Orientation Validation

The following figures show the correlation between manual and automated orientation
angles (Figure 2.18) in addition to the correlation between inter-rater orientation angles
(Figure 2.19). It is important to note the range of each axis when interpreting these
plots. In order to correct for angle sign discrepancies, a correction was applied to the
data so that the smallest difference between two angles was considered. Correlations
with orientation angles revealed significant positive correlations between automated and
manual annotations (r = 0.89, p<0.0001) as well as inter-rater correlations (r = 0.91,
p<0.0001). Figure 2.20 demonstrates the relationship between the eccentricity of an
individual neuron compared to its manually annotated orientation angle. Due to the
nature of the varying shape of neurons, eccentricity of a neuron combined with its angle
of orientation, can be more predictive of directionality compared to orientation angle
alone. Figure 2.21 depicts a vector image of the eccentricity-weighted orientation to
further illustrate this relationship within the cortex.
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Figure 2.18: Spearman correlation of automated and manually annotated orientation
angles; r = 0.89 p<0.0001

Figure 2.19: Spearman correlation of manually annotated orientation angles of two raters;
r = 0.91 p<0.0001
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Figure 2.20: Orientation angle plotted against Eccentricity

Figure 2.21: a) NEUN stained image - EPI P036 b)Vector image of the eccentricityweighted orientation plotted against neuron size feature map. c) Magnified view from
image b. The green lines are average orientation angles in vertical direction, red lines are
horizontally oriented angles
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2.3.4

Clinical Applications

The ANOVA analysis suggests that size, eccentricity and field fraction are all predictive
of cases of focal cortical dysplasia within regions of tissue. However, all features are useful
in the prediction of layering with the cortical architecture and may be used to further
our current understanding of laminar patterns in the neocortex. The ANOVA analysis
indicates that eccentricity is the most useful feature indicative of dysplasia and suggests
that neuron morphology is the biggest factor in assessing abnormalities within cortical
tissue. Orientation was the least indicative of FCD and may be due to the whole-slide
analysis rather than specific regions, such as temporal pole areas, even with variance
taken into consideration. Therefore, a more locally focused analysis may be necessary to
better utilize the orientation metric.
Source

Feature

Corrected P

FCD

Density

0.02772

Size

0.0496*

Orientation Variance

0.2772

Clustering

0.2637

Eccentricity

0.0144*

L1

Field Fraction

0.0280*

L6

Density

<0.0001*

Size

<0.0001*

Orientation Variance

0.1180

Clustering

<0.0001*

Eccentricity

<0.0001*

Field Fraction

<0.0001*

Layer

Layer

L6

Table 2.5: Two-way ANOVA results with a p-value corrected with Holm Bonferroni
method. * denotes significance. For those features with significance in determining
FCD, the last column indicates the most informative layer
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2.4
2.4.1

Discussion
Segmentation & Feature Maps

Compared to manual segmentation, automated cell segmentation and analysis offers several advantages, including the unbiased selection of cells, and the ability to extract large
amounts of quantitative data cell image data sets with large number of images. However,
both manual and fully automated analysis routines can lead to potential problems in
assessing measurement uncertainty quantifying the stain intensity within cells. These
problems include both over- and under-segmentation and overlap of cells due to the the
2-D histology sections. Therefore, the automated segmentation algorithm performed on
the histology images were validated by comparing results with data from slides that were
also manually segmented.
The performed experiments show that the proposed segmentation algorithm produces
good results for most of the histology images used within this study. However, it is
important to consider that segmentation results also depend on the quality of preparation
and on the staining of histology images. Major challenges to this segmentation are
the irregularity of staining however the automated segmentation localizes these areas
by colour deconvolution in order to isolate the DAB stain. The results show that the
obtained binary images from the watershed algorithm can be used for measurements of
cell characteristics. In terms of the segmentation performance, the image characteristics
that led to most neuron detection errors were high cell density, clustering and poor image
contrast with noisy background.
In assessing the quality of the images produced in the feature maps, both neuron size
and neuron density provide clear images of the cortical architecture, particularly when
compared to the field fraction staining alone. The feature maps demonstrating neuron
orientation, clustering and eccentricity prove to have less contrast with the laminar structure, however, these features are predicted to have a more localized benefit in assessing
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neuron integrity within the cortex.

2.4.2

Contouring Validation

The validation study performed to verify the accuracy and reproducibility generated
satisfactory results in locating neurons within a histology slide. The DSC value is a
simple and useful summary measure of spatial overlap, which can be applied to studies of
reproducibility and accuracy in image segmentation. In comparing manual segmentations
between two raters, the DSC value was greater than 0.7 in all cases, indicating a good
overlap. We observed satisfactory results when comparing the spatial overlap between
manual and automated segmentations, with only one instance of a slide having a DSC >
0.7 [20]. This indicates firstly that the automated segmentation performs well compared
with the manual annotations but also that the protocol used for manual annotations is
reproducible and provides a accurate way to delineate neurons within a slide.
Additionally, several Bland-Altman plots were generated in order to analyze any
bias between the two methods (manual vs automated or inter-rater )and to estimate an
agreement interval, within which 95% of the differences of the second method, compared
to the first one. Both neuron size and neuron density metrics were used in this validation
analysis.
The automated method of density compared to the manual segmentation performed
very well as demonstrated in Section 2.3.2. This indicates that the automated segmentation is reliable as a measure of density within the cortex. The automation of calculating
neuron size requires further improvements and the large bias in the current algorithm
indicates over-segmentation and thus reduced cell size. In addition, since averages are
taken and cells are not compared one-to-one, a lot of data demonstrating the size variability within various layers is lost. The basis of the usual histopathological stains are
somewhat difficult to control in terms of intensity of colour (stain), from cell to cell and
more so from section to section, although this may change with the advent of new gener-
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ations of automated stainers. Improvements and optimization of the initial thresholding
operations within the segmentation algorithm would help to correct the disparity in size
between the manual and automated methods.
Although the Bland-Altman plot suggests that the technique used in both cases of
manual annotations is essentially equivalent, one potential source of error leading to
inter-rater differences is the learning curve in segmentation and histology experience as
Rater 2 received less training.

2.4.3

Orientation Validation

The results demonstrate a high correlation between orientation in both automated and
manual annotations (0.89) and the inter-rater manual annotations (0.91). The applied
correction to the angles skewed the data since the range on one set of angles is offset,
however, the results are still interpretable and reliable, indicating that the two sets of
orientation angles are highly correlated.
In addition, the eccentricity can also be used in coordination with orientation. The
more eccentric a neuron is, the more likely the orientation measure will be reliable. Since
these case are most likely pyramidal neurons, moving forward a more specific feature
analysis would only include these neuron types to provide a more accurate representation
of the directionality of neurons within a section of cortex. Using a eccentricity weighted
orientation provides a more informative approach.

2.4.4

Clinical Applications

The ANOVA analysis suggests that size, eccentricity and field fraction are all predictive of
cases of focal cortical dysplasia within regions of tissue. Since field fraction is used so often
in literature this study validates its use as a predictor of abnormal cortex. Eccentricity
also proved to be useful in the prediction of dysplasia and likely relates to abnormal
neuron morphology within FCD cases. Further investigative studies of this measure and
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its ability to locate lesions should be highlighted in future work. In contrast, orientation
variance was the least indicative of FCD and also was not able to distinguish layering
with the cortex. This may be due to the whole-slide analysis rather than specific regions,
therefore, a more locally focused analysis of orientation may be necessary to better utilize
the orientation metric.
All features assessed, with the exception of orientation variance, can be considered
as predictors of layering within the cortical architecture and may be used to further our
current understanding of laminar patterns in the neocortex.
Layer 6 was the most predictive of FCD, within the features found to be significant,
and supports the current literature findings that white matter/layer 6 boundaries may be
poorly defined in FCD [27]. Additionally, Layer 1 was indicative of abnormal eccentricity
in FCD cases. Although layer 1 typically contains only small granular cells that are round
(eccentricity close to zero), the eccentricity value was higher in layer 1 of FCD cases
compared to non-FCD patients, indicating potential abnormal neuron proliferation.
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Chapter 3
Conclusions
The focus of this thesis is to investigate quantitative histological features within the temporal lobe neocortex of patients suffering from drug-resistant epilepsy. This relied on the
development and validation of a segmentation pipeline to individually delineate neurons
in histopathology specimens and extract relevant features from the segmented slides.
Most importantly, I also demonstrated that quantitative histology features can predict
focal cortical dysplasia (FCD) pathology in addition to the cortical laminar structure.
Automatically predicting focal cortical dysplasias from histological tissue specimens
has the potential to reduce pathology workflow and the research undertaken in this thesis
lays the groundwork for the non-invasive localization of pathology.

3.1

Limitations & Future Work

The global hypothesis of this thesis is that the signatures provided by quantitative histology features are able to predict abnormal pathology and with the correlation of MRI,
histology and other diagnostic tools, the goal is to ultimately provide guidance to the
neurosurgeon both prior to and during surgery. There are numerous future directions
necessary to assist surgeons in localizing and resecting the seizure focus and the key to
identifying epileptogenic abnormalities relies heavily on a multi-parametric approach.
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Using quantitative analysis techniques, the various pathologies and abnormalities of
the histopathology in epilepsy lesions can be characterized into digital histology signatures and correlated with MRI. Further MRI-histology in-vivo correlation studies are
necessary in pre-operative visualization and planning. Furthermore, correlation with
functional data such as scalp or intracranial EEG could be used to validate and better understand the relationship between MR imaging, histological features and seizure
propagation in the brain.
SVM training is required to further automate and predict FCD in epilepsy and increased patient dataset would be required to effectively create a pathology prediction
machine. It would also be beneficial to include control tissue from non-epilepsy cases
in order to refine the process and increase the accuracy of prediction. This presents a
challenge, since acquiring histological brain tissue from healthy subjects is not possible.
Older tissue samples are available, however, even with preservation efforts, tissue does
not perform the same as fresh samples recived directly from surgical resections. For this
reason accurate correlation between healthy and abnormal tissue is difficult.
In addition to an increased patient set, the inclusion of more neuron and FCD related
features would allow for a better analysis at both a neuronal and laminar level. For example, this research focused features primarily related to Type I FCD, while the analysis
of features relating to FCD type II and II, such as radial microcolumns and WM neurons,
is necessary. It is also of great importance to correlate the presented histology findings
with seizure outcome and MRI-negative TLE patients need to be examined with multiparametric MRI and quantitative histology validate the effectiveness of these techniques
in lesion detection for this subset of patients. Data would be fed into a machine learning algorithm that determines histological features that correspond to feautures within
MRI. This algorithm will learn the optimal set of feature in a cross-validated manner
to create predictive histology that can help guide the location of epileptogenic lesions
pre-operatively, thus improving resection and surgical outcomes.

Appendix A
Neuron Contouring Protocol
A.1

Contour Specifications

• Manual contours should be performed in ITK-Snap software
• Use only one layer for labelling and set the Paintbrush tool to Shape round and
size 2
• Do not include any neurons that touch the edge of the ROI
• Only those cells that appear as neurons and are stained dark brown should be
included in the segmentation, as defined below:
1. Size:
• The size of the neuron should be at a minimum, 4um in diameter and at a
maximum, 70um in diameter, although these larger neurons are rare. If you
are unsure of this measurement, the diameter of a neuron can be checked in the
Aperio ImageScope software with the ruler tool. See Figure 1 for reference.
The image resolution settings should be set to 0.5 microns/pixel and 20X
magnification.
2. Morphology:
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• The neurons will be either pyramidal or granular neurons. Pyramidal cells
are neurons with a large pyramidal shaped cell body and two dendritic trees
which emerge from both the base and apex of the cell. Granular cells are small
polymorphic neurons. Most of these neurons will be round or oval although
may also have a star-shaped appearance due to dendritic projections.
• Features of a possible neuron may include the presence of dendrites or other
projections and a cell nucleus
• Attached neurons that fit all other criteria should be counted and contoured
as multiple, separate neurons. Neurons may appear overlapped with other
cells, neural debris, or artifacts. In these cases, contour the neuron as best
possible, ignoring the other objects within the slide.
• Do not include neurons that are very irregular in shape and have none of the
above mentioned features of a neuron.
• In addition, do not include the full dendritic branch in the contour. The
dendrite may be included in cases where the NEUN stain in these regions is
as intense as other areas of the cell body. This may mean including only a
small part of the dendritic branch.
3. Staining
• Neurons should be evenly stained and the cell body mostly homogenous in
colour. The cell nucleus, if visible, will be stained with more intensity than
the rest of the neuron.
• Very light brown or blue stained cells should not be included in the contour.

Appendix B
Neuron Orientation Protocol
B.1

Region of Interest

• The regions of interest (ROI) defined from previous annotations will be used
• Load both ROI and one set of previous contour annotations into ITK-Snap software.
The previous segmentation should be loaded as an overlay and the opacity adjusted
as needed.

B.2

Annotation Specifications

• Manual orientation annotations should be performed only on previously annotated
neurons. If a cell was not selected as a neuron previously, do not annotate with
orientation.
• Use label 2 for the new annotations and set the Paintbrush tool to Shape round
and size 3 with the isotropic option checked off.
• To perform the annotation, draw a straight line through the centre of the cell body
– In pyramidal cells:
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∗ The primary dendritic branch should be used to decide the orientation,
running from base to apex.
∗ If there is not a visible dendritic branch use the general morphology of
the neuron to decide the orientation. This should be based on the longest
axis.
– In granular cells:
∗ First consider the presence of any dendritic processes and use those to
assist in annotating the orientation.
∗ Next the morphology of the cell should be assessed and the orientation
can be considered as the diameter in the longest direction.
∗ If none of these factors indicate the orientation, the orientation of surrounding cells should be considered.
• Note: The orientation line may go outside the border of the cell provided that it
does not enter the boundary of another neuron.
• Save the segmentation into the orientation folder

Appendix C
Layer Segmentation Protocol
C.1

Label Specifications

• Manual contours should be performed in Aperio ImageScope Software
• The slide should only be labelled in areas that can be considered non-tangential
cuts and within the plane of the slide, in addition, any areas with staining artifacts
should be excluded.
• Layer 1 is outlined first and starts from above the pial as initial reference. This layer
should extend down through the cortex to lower layers. This process is repeated
for each layer, using layer markers such as the contrast of dense neurons to guide
the user in manually annotating the layers.
• Each layer should overlap from the previous layer such that no space is created between the layers, while still maintaining the boundaries. This overlap is accounted
for and removed in post-processing of the layers, before final analysis in MATLAB.
• Layer 6 is the final layer and should extend further than all other layers but still
stay as much out of the white matter as possible.
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• The resulting .xml annotation files are converted to readable MATLAB data for
further analysis.

Curriculum Vita

Charlotte Blinston, B.Cmp.H.
Imaging Research Laboratories
Robarts Research Institute
EDUCATION
Sept. 2012 –
present

Master of Engineering Science (Candidate)
Biomedical Engineering Graduate Program
Western University, London, Ontario, Canada
Supervisors: Terry Peters, Ph.D, Ali Khan, Ph.D
Thesis: “Histological Quantification in Temporal Lobe Epilepsy”

Sept. 2008 –
June 2012

Bachelor of Computing, Honours
Specialization in Biomedical Computer Science
Queen’s University, Kingston, Ontario, Canada
Undergraduate Project: “Analysis of sensorimotor dysfunction in stroke
subjects”
POSITIONS

Jan. 2013 –
April 2014

Lead Graduate Teaching Assistant
ES1036B: Programming Fundamentals for Engineers (C++)
Department of Electrical and Computer Engineering
Western University, London, Ontario, Canada

June 2012 –
Sept. 2012

Summer Student
Department of Knowledge and Innovation
Chatham Kent Health Alliance, Chatham, Ontario, Canada

Sept. 2011 –
May 2012

Undergraduate Research Assistant
Molecular Scene Analysis Laboratory
School of Computing, Queen’s University, Kingston, Ontario, Canada
Supervisor: Janice Glasgow, Ph.D.
Project: “Analysis of sensorimotor dysfunction in stroke subjects”

May 2011 –
Sept. 2011

Undergraduate Summer Research Assistant
Molecular Scene Analysis Laboratory
School of Computing, Queen’s University, Kingston, Ontario, Canada
Supervisor: Janice Glasgow, Ph.D.
Project: “Design, implementation and evaluation of a case-based reasoning
system for the diagnosis of impairment and for the planning of
rehabilitation strategies for patients with stroke”.

ACADEMIC AWARDS and SCHOLARSHIPS
Sept. 2012 –
Aug. 2014

Western Graduate Research Scholarship
Awarded to a full time graduate student for tuition support who has
maintained an average of 80% or more

May 2011

Ian Lawson Van Toch Summer Research Fellowship in Biomedical
Computing
Awarded to a student in the Biomedical Computing program at Queen’s
University in order to complete summer research

Sept. 2008 –
June 2012

Queen's University Excellence Scholarship
Awarded upon admission to Queen’s students who have an admission
average of 90.0 - 94.9%

Sept. 2008

The Queen Elizabeth II Aiming for the Top Scholarship
Awarded to students who have shown academic excellence at the high school
level
PUBLISHED JOURNAL MANUSCRIPTS (1)

1. Goubran, M., Bernhardt, B. C., Cantor-Rivera, D., Lau, J. C., Blinston, C., Hammond,
R. R., de Ribaupierre, S., Burneo, J. G., Mirsattari, S. M., Steven, D. A., Parrent, A. G.,
Bernasconi, A., Bernasconi, N., Peters, T. M., Khan, A. R., “In vivo MRI signatures of
hippocampal subfield pathology in intractable epilepsy”. Human Brain Mapping 2016;
37 (3): 1103-1119
ORAL PRESENTATIONS (1) *presenter
1. C. Blinston*, M. Goubran, T. Peters, R. Hammond, A.R. Khan. “Imaging Techniques
for Histology Quantification in Medically Intractable TLE”. LHSC Epilepsy Research
Day, London, Ontario, Canada (Nov 4 2016)
2. C. Blinston, M. Goubran*, T. Peters, R. Hammond, A.R. Khan. “Computational
imaging techniques for neuron-specific quantification of cortical architecture in
temporal lobe epilepsy”. London Imaging Discovery Day, London, Ontario, Canada
(June 26 2014)
POSTER PRESENTATIONS (5)
1. C. Blinston, T. Peters, R. Hammond, A.R. Khan. “Computational Imaging Techniques
for Histological Quantification of Cortical Architecture in Epilepsy”. Imaging Network
Ontario Symposium, Toronto, Ontario, Canada (March 24-25 2014)

2. C. Blinston, T. Peters, R. Hammond, A.R. Khan. “Computational Imaging Techniques
for Histological Quantification of Cortical Architecture in Epilepsy”. London Health
Research Day, Schulich School of Medicine and Dentistry, Western University,
London, Ontario, Canada (March 18 2014)
3. C. Blinston, R. Hammond, M. Goubran, A. Parrent, J.G. Burneo,S. De Ribaupierre, D.
Steven, T. Peters, A. R. Khan. “Quantitative analysis of neocortical architecture in
refractory temporal lobe epilepsy”. American Epilepsy Society Annual Meeting,
Washington, D.C., USA (Dec 8 2013)
4. C. Blinston, T. Peters, R. Hammond, A.R. Khan. “Quantitative characterization of
neuropathology in temporal lobe epilepsy”. London Health Research Day, Schulich
School of Medicine and Dentistry, Western University, London, Ontario, Canada
(March 19 2013)
5. C. Blinston, K. Tyryshkin, J. Glasgow. “Analysis of sensorimotor dysfunction in stroke
subjects”. Creative Computing: Art, Games, Research. School of Computing, Queen’s
University, Kingston, Ontario, Canada (April 5 2012)
PROFESSIONAL MEMBERSHIPS
2013 Present

Biomedical Engineering Society, Student Member

IEEE Membership, Student Member
IEEE Women in Engineering Membership, Student Member
RELEVANT GRADUATE COURSES
Biomedical Engineering Graduate Program, Western University, London, Ontario, Canada

/13

Jan 2015 –
April 2015

VASCPROG 9603

Research Ethics And Biostatistics

Jan. 2013 –
April 2013

BME 9511
BME 9550

Image-Guided Interventions
Principles of Communication and Knowledge
Translation for Biomedical Engineers

Sep. 2012 –
Dec. 2012

BME 9509
BME 9501

Digital Image Processing
Introduction to Biomedical Engineering

